Graphite Bio, Inc. has entered into a merger agreement with Lenz Therapeutics, Inc., and its stockholders have approved a reverse stock split and a name change to LENZ Therapeutics, Inc.
AI Assistant
LENZ THERAPEUTICS INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.